Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
Hamashima
T
T
Department of Surgery, University of Texas Medical School at Houston 77030.
Stepkowski
S M
SM
Smith
S
S
Kahan
B D
BD
D000818:Animals; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D016027:Heart Transplantation / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000302:isolation & purification / Q000627:therapeutic use*; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008214:Lymphocytes / Q000276:immunology; D011090:Polyenes / Q000627:therapeutic use*; D011189:Potassium Chloride; D051381:Rats; D011914:Rats, Inbred BN; D011920:Rats, Inbred WF; D017207:Rats, Sprague-Dawley; D020123:Sirolimus; D013154:Spleen / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D006649:Histocompatibility Antigens; D007166:Immunosuppressive Agents; D011090:Polyenes; D011189:Potassium Chloride; D016572:Cyclosporine; D020123:Sirolimus